Skip to content

Treatment effects in clients of the Forensic Psychiatric Clinic in Assen

Treatment effects in clients of the Forensic Psychiatric Clinic in Assen - Treatment efficacy at the FPK-Assen

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON29920
Enrollment
300
Registered
2006-09-11
Start date
2006-12-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychiatric/personality disorders in forensic patients

Interventions

None listed

Sponsors

GGZ Drenthe (Assen)
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inpatients of the FPK in Assen

Exclusion criteria

Exclusion criteria: If the patient does not want to participate in this study If the duration of the admission to the FPK is less than 6 months If the patient is not admitted to the clinic for treatment purposes

Design outcomes

Primary

MeasureTime frame
The following set of hypothesis will be examined during the patient's stay in the clinic: - do the mental/psychiatric problems diminish? - does the patient exhibit less agressive behaviour? - does social functioning improve? - is the risk of committing a crime reduced? - does the number of aggressive incidents decrease? After the patient leaves the clinic the following hypothesis will be examined: - are the reductions in mental/psychiatric problems maintained? - does the decrease in agressive behaviour persist? - does social functioning maintain at a relatively high level? - does the risk of committing a crime remain low? - no recidivism? In addition to this, at the end of the treatment in the clinic it will be examined how satisfied/unsatisfied the patients are with the treatment and the different parts of the treatment by means of a questionnaire. In the future it will be examined if DNA polymorphisms contribute to the existence of psychiatric/personality disturbances and/or the efficacy of medication and other therapies.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)